FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Cellular Biomedicine Group Announces Closing of $10 Million Private Placement Offering
June 20, 2014
NeoStem Announces Licensing Agreement and Plans to Begin Phase 2 Hepatocellular Carcinoma Trial in China
May 13, 2014
Cellular Biomedicine Group Releases Positive Six-Month Data From Phase I/IIa Clinical Trial for ReJoin(TM) Treatment of Knee Osteoarthritis (KOA)
June 19, 2014
Cellular Biomedicine Group Commences Trading of Its Common Stock on The NASDAQ Capital Market
June 18, 2014
Cellular Biomedicine Group Releases Positive Results From Phase I Clinical Trial for Hepatocellular Carcinoma
March 24, 2014
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here